DE60122216D1 - Zolpidem Hemitartrat Solvat - Google Patents

Zolpidem Hemitartrat Solvat

Info

Publication number
DE60122216D1
DE60122216D1 DE60122216T DE60122216T DE60122216D1 DE 60122216 D1 DE60122216 D1 DE 60122216D1 DE 60122216 T DE60122216 T DE 60122216T DE 60122216 T DE60122216 T DE 60122216T DE 60122216 D1 DE60122216 D1 DE 60122216D1
Authority
DE
Germany
Prior art keywords
zolpidem hemitartrate
solvate
hemitartrate solvate
zolpidem
polymorphs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60122216T
Other languages
English (en)
Other versions
DE60122216T2 (de
Inventor
Judith Aronhime
David Leonov
Erzebet Meszaros-Sos
Szaboles Salyi
Csaba Szabo
Shlomo Zavurov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27394001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60122216(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of DE60122216D1 publication Critical patent/DE60122216D1/de
Application granted granted Critical
Publication of DE60122216T2 publication Critical patent/DE60122216T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Other Liquid Machine Or Engine Such As Wave Power Use (AREA)
  • Suspension Of Electric Lines Or Cables (AREA)
  • Amplifiers (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60122216T 2000-04-24 2001-04-24 Zolpidem Hemitartrat Solvat Expired - Fee Related DE60122216T2 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US19929800P 2000-04-24 2000-04-24
US199298P 2000-04-24
US20602500P 2000-05-22 2000-05-22
US206025P 2000-05-22
US22536400P 2000-08-14 2000-08-14
US225364P 2000-08-14

Publications (2)

Publication Number Publication Date
DE60122216D1 true DE60122216D1 (de) 2006-09-21
DE60122216T2 DE60122216T2 (de) 2007-08-30

Family

ID=27394001

Family Applications (7)

Application Number Title Priority Date Filing Date
DE04010435T Pending DE04010435T1 (de) 2000-04-24 2001-04-24 Zolpidem Hemitartrat Solvat
DE04010651T Pending DE04010651T1 (de) 2000-04-24 2001-04-24 Mikronisiertes Zolpidem-Hemitartrat
DE60114617T Expired - Fee Related DE60114617T2 (de) 2000-04-24 2001-04-24 Zolpidem hemitartrat
DE60122944T Expired - Fee Related DE60122944T2 (de) 2000-04-24 2001-04-24 Mikronisiertes Zolpidem-Hemitartrat
DE20122435U Expired - Lifetime DE20122435U1 (de) 2000-04-24 2001-04-24 Mikronisiertes Zolpidem-Hemitartrat
DE60122216T Expired - Fee Related DE60122216T2 (de) 2000-04-24 2001-04-24 Zolpidem Hemitartrat Solvat
DE60125429T Expired - Fee Related DE60125429T2 (de) 2000-04-24 2001-04-24 Zolpidem hemitartrat solvat

Family Applications Before (5)

Application Number Title Priority Date Filing Date
DE04010435T Pending DE04010435T1 (de) 2000-04-24 2001-04-24 Zolpidem Hemitartrat Solvat
DE04010651T Pending DE04010651T1 (de) 2000-04-24 2001-04-24 Mikronisiertes Zolpidem-Hemitartrat
DE60114617T Expired - Fee Related DE60114617T2 (de) 2000-04-24 2001-04-24 Zolpidem hemitartrat
DE60122944T Expired - Fee Related DE60122944T2 (de) 2000-04-24 2001-04-24 Mikronisiertes Zolpidem-Hemitartrat
DE20122435U Expired - Lifetime DE20122435U1 (de) 2000-04-24 2001-04-24 Mikronisiertes Zolpidem-Hemitartrat

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60125429T Expired - Fee Related DE60125429T2 (de) 2000-04-24 2001-04-24 Zolpidem hemitartrat solvat

Country Status (21)

Country Link
US (8) US20020077332A1 (de)
EP (1) EP1292304B1 (de)
JP (3) JP2003531173A (de)
KR (1) KR20030069796A (de)
AT (4) ATE335481T1 (de)
AU (2) AU2001257213B2 (de)
CA (1) CA2406982A1 (de)
CZ (1) CZ20023775A3 (de)
DE (7) DE04010435T1 (de)
DK (1) DK1292304T3 (de)
ES (4) ES2277301T3 (de)
HR (1) HRP20020909A2 (de)
HU (1) HUP0300701A2 (de)
IL (1) IL152411A0 (de)
NZ (1) NZ522015A (de)
PL (1) PL358548A1 (de)
PT (3) PT1541146E (de)
SE (1) SE5292304T3 (de)
SK (1) SK16372002A3 (de)
WO (1) WO2001080857A1 (de)
YU (1) YU79402A (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6921839B2 (en) 2000-08-29 2005-07-26 Ranbaxy Laboratories Limited Synthesis of N,N-dimethyl-3-(4-methyl) benzoyl propionamide a key intermediate of zolpidem
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
US7385056B2 (en) 2002-12-18 2008-06-10 Mallinckrodt Inc. Synthesis of heteroaryl acetamides
WO2004087703A1 (en) * 2003-03-12 2004-10-14 Sun Pharmaceutical Industries Limited Process for the preparation of n,n,6-trimethyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-3-acetamide
WO2005010002A1 (en) * 2003-07-31 2005-02-03 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
KR20070030178A (ko) * 2004-02-17 2007-03-15 트랜스오랄 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의사용 방법
US20080262025A1 (en) * 2004-07-16 2008-10-23 Yatendra Kumar Processes for the Preparation of Zolpidem and its Hemitartrate
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
US20060276501A1 (en) * 2005-05-25 2006-12-07 Transoral Pharmaceuticals, Inc. Solid compositions for treating middle-of-the-night insomnia
KR20080038416A (ko) * 2005-08-19 2008-05-06 아벤티스 파마슈티칼스 인크. 수면제와 치환된 비스 아릴 및 헤테로아릴 화합물의 배합물및 이의 치료요법적 용도
JP2009504760A (ja) * 2005-08-19 2009-02-05 アベンティス・ファーマスーティカルズ・インコーポレイテツド 催眠剤及びＲ（＋）−α−（２，３−ジメトキシ−フェニル）−１−［２−（４−フルオロフェニル）エチル］−４−ピペリジンメタノールの組み合わせ物並びに治療でのその使用
AU2006297475A1 (en) * 2005-10-03 2007-04-12 Mallinckrodt Inc. Process for preparing zolpidem hemitartrate and tartrate polymorphs
AU2006303000A1 (en) * 2005-10-17 2007-04-26 Mallinckrodt Inc. Polymorph transformation of Zolpidem in tablet matrix
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
US7507737B2 (en) 2006-03-31 2009-03-24 Janssen Pharmaceutica, N.V. Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4receptor
US20080132535A1 (en) * 2006-11-30 2008-06-05 Transcept Pharmaceuticals, Inc. Stabilized Zolpidem Pharmaceutical Compositions
US20080145425A1 (en) * 2006-12-15 2008-06-19 Pliva Research & Development Limited Pharmaceutical composition of zolpidem
NZ599747A (en) * 2008-06-30 2013-03-28 Janssen Pharmaceutica Nv Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
HUE029371T2 (en) 2009-11-27 2017-02-28 Genzyme Corp GENZ 112638 For treatment of Gaucher or Fabry disease in combination therapy
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
SG11201507117XA (en) 2013-03-06 2015-10-29 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
IT1130924B (it) * 1980-03-06 1986-06-18 Secifarma Spa Procedimento per la preparazione di spironolattone micronizzato
DE3018940A1 (de) * 1980-05-17 1981-11-26 Hoechst Ag, 6000 Frankfurt Verwendung eines vinylchlorid-pfropf-copolymerisates in der plastisolverarbeitung
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
FR2525601A1 (fr) * 1982-04-21 1983-10-28 Synthelabo Derives d'imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
US4675323A (en) * 1985-08-06 1987-06-23 Synthelabo Imidazo(1,2-a)quinoline derivatives useful as anxiolytic agents
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
FR2600650B1 (fr) * 1986-06-27 1988-09-09 Synthelabo Procede de preparation d'imidazopyridines et composes intermediaires
FR2606410B1 (fr) * 1986-11-07 1989-02-24 Synthelabo Imidazopyridines, leur preparation et leur application en therapeutique
DE3865073D1 (de) * 1987-03-27 1991-10-31 Synthelabo Imidazopyridinderivate, ihre herstellung und therapeutische verwendung.
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
IT1276522B1 (it) * 1995-04-07 1997-10-31 Elena Benincasa Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei
EP1038875B1 (de) * 1999-03-25 2003-06-04 Synthon B.V. Imidazopyridinderivate und Verfahren zu ihrer Herstellung
DE60020814T2 (de) * 1999-03-25 2006-05-04 Synthon B.V. Zolpidem salze
AU6474200A (en) * 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound

Also Published As

Publication number Publication date
HRP20020909A2 (en) 2004-08-31
DE60114617D1 (de) 2005-12-08
DE60114617T2 (de) 2006-07-27
IL152411A0 (en) 2003-05-29
DE60122944T2 (de) 2007-04-12
EP1292304A1 (de) 2003-03-19
ES2277301T3 (es) 2007-07-01
ES2239558T3 (es) 2007-04-01
US20040220210A1 (en) 2004-11-04
US20070037843A1 (en) 2007-02-15
CA2406982A1 (en) 2001-11-01
NZ522015A (en) 2004-08-27
WO2001080857A1 (en) 2001-11-01
PL358548A1 (en) 2004-08-09
DE04010651T1 (de) 2005-09-01
SK16372002A3 (sk) 2003-04-01
EP1292304B1 (de) 2005-11-02
DE60125429T2 (de) 2007-09-27
US20040220212A1 (en) 2004-11-04
KR20030069796A (ko) 2003-08-27
AU5721301A (en) 2001-11-07
CZ20023775A3 (cs) 2003-10-15
ATE338550T1 (de) 2006-09-15
JP2006137778A (ja) 2006-06-01
EP1292304A4 (de) 2003-07-23
PT1473036E (pt) 2006-10-31
US20020077332A1 (en) 2002-06-20
YU79402A (sh) 2006-03-03
JP2003531173A (ja) 2003-10-21
AU2001257213B2 (en) 2005-09-29
ES2248321T3 (es) 2006-03-16
ATE348613T1 (de) 2007-01-15
DK1292304T3 (da) 2005-12-19
ES2239558T1 (es) 2005-10-01
DE60122216T2 (de) 2007-08-30
HUP0300701A2 (hu) 2003-07-28
DE20122435U1 (de) 2005-10-06
DE60122944D1 (de) 2006-10-19
DE60125429D1 (de) 2007-02-01
ATE308324T1 (de) 2005-11-15
US20040214859A1 (en) 2004-10-28
ATE335481T1 (de) 2006-09-15
ES2238941T3 (es) 2007-04-01
ES2238941T1 (es) 2005-09-16
WO2001080857A9 (en) 2002-06-27
PT1541146E (pt) 2007-01-31
US20040214858A1 (en) 2004-10-28
US20040220213A1 (en) 2004-11-04
JP2006249105A (ja) 2006-09-21
SE5292304T3 (de) 2005-11-02
DE04010435T1 (de) 2005-09-01
US20040220211A1 (en) 2004-11-04
PT1475093E (pt) 2006-11-30

Similar Documents

Publication Publication Date Title
DE60122216D1 (de) Zolpidem Hemitartrat Solvat
DK1543002T3 (da) Fremstilling af 1H-imidazo (4,5-c) quinolin-4-aminer via 1H-imidazo (4,5-c) quinolin-4-phtalimid mellemprodukter
DK1412328T3 (da) Dolastatin-10-derivater
IS6448A (is) Bakteríuskæð 3-amónóqínazólin-2.4díon hrifefni
ATE302775T1 (de) Carbolinderivate
NO20052794L (no) Antibakterielle indolonoksazolidinoner intermediater for fremstilling av disse og farmasoytiske prepareter inneholdende disse
ATE346067T1 (de) Carbolinderivate
DK1328538T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af 7-substituerede antiöstrogener
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
ITMI20021822A1 (it) Manicotto elastico e procedimento per la fabbricazione di un manicotto elastico
NO20043107L (no) Bronnsementeringsbestanddeler for kalde omgivelser
ATE315380T1 (de) Epothilon zusammensetzungen
ITMI20001695A0 (it) Procedimento per la preparazione di composizioni organico-sili-coniche.
ATE335742T1 (de) Carbolinderivate als pdev inhibitoren
NO20053829L (no) Fremgangsmate og intermediater for fremstilling av olanzapin.
NO20042542L (no) Anvendelse av ascomycin for behandling av blefarit
NO20033840D0 (no) Fremgangsmåte for fremstilling av mirtazapinmellomprodukter
ITMI20012131A0 (it) Procedimento per la preparazione di alo-benzonitrili
CY1115144T1 (el) Παραγωγα του uk-2a
ITMI20001600A0 (it) Procedimento per la preparazione di 5-amino-4-alo-3-alchil isossazoli.
ITTO20000397A0 (it) Procedimento perfezionato per la preparazione di 4-alchil-3-alcossianiline.
IT250811Y1 (it) Canaletta modulare componibile per la estensione di condutture elettriche o simili partendo da punti di alimentazione in crene.
ES1045504Y (es) Mueble expositor de piezas ceramicas.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee